- Home
- FINW vs TARA Comparison
FINW vs TARA Comparison
Compare FINW & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FINW | TARA |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 245.2M | 268.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | FINW | TARA |
|---|---|---|
| Price | $17.35 | $6.52 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $21.00 |
| AVG Volume (30 Days) | 31.3K | ★ 1.2M |
| Earning Date | 01-29-2026 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.51 | N/A |
| EPS | ★ 1.13 | N/A |
| Revenue | ★ $92,093,000.00 | N/A |
| Revenue This Year | $92.23 | N/A |
| Revenue Next Year | $23.28 | N/A |
| P/E Ratio | $15.59 | ★ N/A |
| Revenue Growth | ★ 31.91 | N/A |
| 52 Week Low | $13.49 | $2.77 |
| 52 Week High | $22.49 | $7.82 |
Technical Indicators
Market Signals| Indicator | FINW | TARA |
|---|---|---|
| Relative Strength Index (RSI) | 43.84 | 56.47 |
| Support Level | $17.55 | $6.41 |
| Resistance Level | $19.04 | $7.33 |
| Average True Range (ATR) | 0.59 | 0.50 |
| MACD | -0.06 | 0.05 |
| Stochastic Oscillator | 6.84 | 67.27 |
Price Performance
Historical ComparisonAbout FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).